Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 41 | $15,255,881 |
Sells | 29 | $4,824,841 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Mar 2025 19:50 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 18 Mar 2025 | Purchase | 14,740 | 14.4233 | 212,599 | D |
20 Mar 2025 19:50 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 19 Mar 2025 | Purchase | 20,234 | 14.9729 | 302,962 | D |
20 Mar 2025 19:50 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 20 Mar 2025 | Purchase | 54,889 | 15.5877 | 855,593 | D |
15 Jan 2025 16:08 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 13 Jan 2025 | Purchase | 7,962 | 16.8576 | 134,220 | D |
15 Jan 2025 16:08 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 13 Jan 2025 | Purchase | 8,983 | 17.7822 | 159,738 | D |
15 Jan 2025 16:08 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 14 Jan 2025 | Purchase | 4,022 | 18 | 72,396 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 03 Jan 2025 | Sale | 2,417 | 16.7219 | 40,417 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 06 Jan 2025 | Sale | 2,458 | 16.8322 | 41,374 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | MILJKOVIC MILOS | Chief Medical Officer | 03 Jan 2025 | Sale | 932 | 16.7219 | 15,585 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | MILJKOVIC MILOS | Chief Medical Officer | 06 Jan 2025 | Sale | 948 | 16.8322 | 15,957 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | JEWELL CHRISTOPHER M | Chief Scientific Officer | 03 Jan 2025 | Sale | 1,264 | 16.7219 | 21,136 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | JEWELL CHRISTOPHER M | Chief Scientific Officer | 06 Jan 2025 | Sale | 1,286 | 16.8322 | 21,646 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | ENGLISH EMILY | Chief Operations Officer | 03 Jan 2025 | Sale | 891 | 16.7219 | 14,899 | D |
07 Jan 2025 20:05 | RNAC | Cartesian Therapeutics Inc | ENGLISH EMILY | Chief Operations Officer | 06 Jan 2025 | Sale | 906 | 16.8322 | 15,250 | D |
07 Jan 2025 20:04 | RNAC | Cartesian Therapeutics Inc | BRUNN CARSTEN | President and CEO | 03 Jan 2025 | Sale | 8,563 | 16.7219 | 143,190 | D |
07 Jan 2025 20:04 | RNAC | Cartesian Therapeutics Inc | BRUNN CARSTEN | President and CEO | 06 Jan 2025 | Sale | 8,708 | 16.8322 | 146,575 | D |
07 Jan 2025 20:04 | RNAC | Cartesian Therapeutics Inc | DAVIS BLAINE | Chief Financial Officer | 03 Jan 2025 | Sale | 3,961 | 16.7219 | 66,235 | D |
07 Jan 2025 20:04 | RNAC | Cartesian Therapeutics Inc | DAVIS BLAINE | Chief Financial Officer | 06 Jan 2025 | Sale | 4,028 | 16.8322 | 67,800 | D |
23 Dec 2024 17:20 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 19 Dec 2024 | Purchase | 11,303 | 17.3858 | 196,512 | D |
23 Dec 2024 17:20 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 19 Dec 2024 | Purchase | 10,529 | 18.3496 | 193,203 | D |
23 Dec 2024 17:20 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 19 Dec 2024 | Purchase | 3,376 | 18.928 | 63,901 | D |
23 Dec 2024 17:20 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 20 Dec 2024 | Purchase | 21,800 | 18.9435 | 412,968 | D |
23 Dec 2024 17:20 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 23 Dec 2024 | Purchase | 5,181 | 18.9996 | 98,437 | D |
11 Dec 2024 16:28 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 09 Dec 2024 | Sale | 6,224 | 25.2629 | 157,236 | D |
11 Dec 2024 16:28 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 09 Dec 2024 | Sale | 4,539 | 25.8333 | 117,257 | D |
11 Dec 2024 16:28 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 10 Dec 2024 | Sale | 2,901 | 24.3503 | 70,640 | D |
21 Nov 2024 18:52 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 19 Nov 2024 | Sale | 200 | 19.5 | 3,900 | D |
21 Nov 2024 18:52 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 20 Nov 2024 | Sale | 5,600 | 17.2787 | 96,761 | D |
21 Nov 2024 18:52 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 20 Nov 2024 | Sale | 100 | 18.09 | 1,809 | D |
21 Nov 2024 18:52 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 21 Nov 2024 | Sale | 32,789 | 16.669 | 546,560 | D |
18 Nov 2024 19:35 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 14 Nov 2024 | Purchase | 74,157 | 16.1916 | 1,200,720 | D |
18 Nov 2024 19:35 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 14 Nov 2024 | Purchase | 22,242 | 16.9695 | 377,436 | D |
18 Nov 2024 19:35 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 15 Nov 2024 | Purchase | 277,246 | 17.0938 | 4,739,188 | D |
18 Nov 2024 19:35 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 18 Nov 2024 | Purchase | 38,114 | 17.9579 | 684,447 | D |
18 Nov 2024 19:35 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 18 Nov 2024 | Purchase | 20,181 | 18.4201 | 371,736 | D |
18 Nov 2024 19:32 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 14 Nov 2024 | Sale | 21,900 | 16.3308 | 357,645 | D |
18 Nov 2024 19:32 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 14 Nov 2024 | Sale | 4,000 | 17.0639 | 68,256 | D |
18 Nov 2024 19:32 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 15 Nov 2024 | Sale | 22,068 | 17.1967 | 379,497 | D |
18 Nov 2024 19:32 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 18 Nov 2024 | Sale | 16,672 | 18.1869 | 303,212 | D |
18 Nov 2024 19:32 | RNAC | Cartesian Therapeutics Inc | KURTOGLU METIN | Chief Technology Officer | 18 Nov 2024 | Sale | 17,728 | 18.5824 | 329,429 | D |
18 Nov 2024 19:28 | RNAC | Cartesian Therapeutics Inc | MILJKOVIC MILOS | Chief Medical Officer | 14 Nov 2024 | Sale | 35,000 | 16.1327 | 564,644 | D |
18 Nov 2024 19:28 | RNAC | Cartesian Therapeutics Inc | MILJKOVIC MILOS | Chief Medical Officer | 15 Nov 2024 | Sale | 20,000 | 17.1444 | 342,888 | D |
18 Nov 2024 19:23 | RNAC | Cartesian Therapeutics Inc | JEWELL CHRISTOPHER M | Chief Scientific Officer | 14 Nov 2024 | Sale | 18,550 | 16.341 | 303,126 | D |
18 Nov 2024 19:23 | RNAC | Cartesian Therapeutics Inc | JEWELL CHRISTOPHER M | Chief Scientific Officer | 14 Nov 2024 | Sale | 17,500 | 17.0185 | 297,824 | D |
18 Nov 2024 19:23 | RNAC | Cartesian Therapeutics Inc | JEWELL CHRISTOPHER M | Chief Scientific Officer | 15 Nov 2024 | Sale | 16,065 | 17.0615 | 274,093 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 02 Oct 2024 | Purchase | 5,514 | 17.3779 | 95,822 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 03 Oct 2024 | Purchase | 29,847 | 18.2456 | 544,576 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 03 Oct 2024 | Purchase | 10,249 | 19.0125 | 194,859 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 03 Oct 2024 | Purchase | 50,489 | 20.1802 | 1,018,878 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 03 Oct 2024 | Purchase | 21,278 | 21.1749 | 450,560 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 03 Oct 2024 | Purchase | 8,043 | 21.8625 | 175,840 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 04 Oct 2024 | Purchase | 9,892 | 21.3501 | 211,195 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 04 Oct 2024 | Purchase | 48,880 | 22.3542 | 1,092,673 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 04 Oct 2024 | Purchase | 16,650 | 23.5659 | 392,372 | D |
04 Oct 2024 17:58 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 04 Oct 2024 | Purchase | 4,879 | 23.933 | 116,769 | D |
14 Aug 2024 16:43 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 12 Aug 2024 | Purchase | 8,016 | 12.7205 | 101,968 | I |
14 Aug 2024 16:41 | RNAC | Cartesian Therapeutics Inc | BARABE TIMOTHY C | Director | 12 Aug 2024 | Purchase | 7,500 | 12.7 | 95,250 | D |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 18 Mar 2024 | Purchase | 800 | 0.61 | 488 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 15 Mar 2024 | Purchase | 1,200 | 0.56 | 672 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 14 Mar 2024 | Purchase | 2,000 | 0.5305 | 1,061 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 13 Mar 2024 | Purchase | 3,200 | 0.5837 | 1,868 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 12 Mar 2024 | Purchase | 1,200 | 0.6122 | 735 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 11 Mar 2024 | Purchase | 1,200 | 0.6541 | 785 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 08 Mar 2024 | Purchase | 4,800 | 0.6639 | 3,187 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 07 Feb 2024 | Purchase | 2,400 | 0.6563 | 1,575 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 17 Jan 2024 | Purchase | 800 | 0.69 | 552 | I |
28 Mar 2024 17:11 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 06 Feb 2024 | Purchase | 800 | 0.65 | 520 | I |
20 Mar 2024 17:09 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 18 Mar 2024 | Purchase | 19,044 | 0.5985 | 11,398 | I |
18 Mar 2024 17:29 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 15 Mar 2024 | Purchase | 537,500 | 0.5852 | 314,545 | I |
18 Mar 2024 17:29 | RNAC | Cartesian Therapeutics Inc | SPRINGER TIMOTHY A | Director , 10% | 14 Mar 2024 | Purchase | 648,372 | 0.5424 | 351,677 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)